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        Introduction 
  Ezrin/radixin/moesin (ERM) proteins link the cortical cytoskel-
eton to the plasma membrane. In their active conformation, the 
N-terminal FERM (protein 4.1 ERM) domain binds to the cyto-
plasmic tails of transmembrane proteins, and the C-terminal 
ERM association domain (C-ERMAD) region binds to actin fi  l-
aments (  Bretscher et al., 2002  ;   Fievet et al., 2007  ;   Hughes and 
Fehon, 2007  ;   Niggli and Rossy, 2008  ). However, ERMs also 
exist in a dormant or autoinhibited conformation in which the 
binding sites on the FERM domain are masked by the remain-
der of the molecule, including an     200-residue linker and the 
C-ERMAD (  Pearson et al., 2000  ;   Li et al., 2007  ). Transition of 
ERM proteins to an active conformation (i.e., release of auto-
inhibition) occurs by two distinct mechanisms: (1) binding of the 
FERM domain to membrane rich in phosphatidylinositol 4,5-
bisphosphate (PIP2) and (2) phosphorylation of the C-ERMAD. 
After a decade of elegant in vitro and in vivo studies, a domi-
nant current view is that activation occurs in a two-step fashion 
(  Bretscher et al., 2002  ;   Fievet et al., 2007  ;   Hughes and Fehon, 
2007  ;   Niggli and Rossy, 2008  ). First, PIP2 binding induces a 
conformational change and partial activation (  Barret et al., 
2000  ;   Yonemura et al., 2002  ). Second, because that conforma-
tional change has made the phosphorylation site accessible, 
C-terminal phosphorylation can occur (  Fievet et al., 2004  ). When 
phosphorylated, ERM proteins are active (  Matsui et al., 1998  ; 
  Huang et al., 1999  ;   Nakamura et al., 1999  ). According to a re-
cent study (  Fievet et al., 2004  ), phosphorylated ERM (pERM) 
proteins are active without PIP2. 
  Although activation is the focus of studies of ERM protein 
regulation in most cells, ERM protein inactivation is also bio-
logically important, particularly in cytoskeletal reorganization 
(  Brown et al., 2001  ;   Zeidan et al., 2008  ). Acute ERM protein 
inactivation plays a critical physiological role in lymphocytes. 
Lymphocyte recirculation from blood into tissue then back into 
blood is crucial for effi  cient immune responses (  Laudanna and 
Alon, 2006  ;   Rose et al., 2007  ). While in blood, the cytoskeleton 
of the lymphocyte assures that it is spherical and relatively rigid, 
allowing it to survive the hemodynamic rigors of circulation. 
Regulated binding to vascular endothelium and migration into tis-
sue are triggered by molecules termed chemokines on the endo-
thelial surface that activate G protein – coupled receptors (GPCRs) 
on the lymphocyte. One very rapid consequence is global re-
organization of cytoskeleton into a confi  guration appropriate 
M
echanisms controlling the disassembly of ezrin/
radixin/moesin (ERM) proteins, which link the 
cytoskeleton to the plasma membrane, are in-
completely understood. In lymphocytes, chemokine (e.g., 
SDF-1) stimulation inactivates ERM proteins, causing their 
release from the plasma membrane and dephosphory-
lation. SDF-1  –  mediated inactivation of ERM proteins is 
blocked by phospholipase C (PLC) inhibitors. Conversely, 
reduction of phosphatidylinositol 4,5-bisphosphate (PIP2) 
levels by activation of PLC, expression of active PLC mu-
tants, or acute targeting of phosphoinositide 5-phosphatase 
to the plasma membrane promotes release and dephos-
phorylation of moesin and ezrin. Although expression of 
phosphomimetic moesin (T558D) or ezrin (T567D) mu-
tants enhances membrane association, activation of PLC 
still relocalizes them to the cytosol. Similarly, in vitro bind-
ing of ERM proteins to the cytoplasmic tail of CD44 is also 
dependent on PIP2. These results demonstrate a new role 
of PLCs in rapid cytoskeletal remodeling and an addi-
tional key role of PIP2 in ERM protein biology, namely 
hydrolysis-mediated ERM inactivation.
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based on (a) the importance of PIP2 in the aforementioned ERM 
activation and (b) the role of PLC in GPCR signaling, generally and 
specifi  cally in chemokine-induced T lymphocyte migration ( Bacon 
et al., 1995  ;   Smit et al., 2003  ;   Soriano et al., 2003  ;   Cronshaw et al., 
2006  ;   Bach et al., 2007  ). We fi  nd that chemokine-induced inactiva-
tion of lymphocyte ERM proteins (ezrin and moesin) is mediated 
by the reduction of PIP2 that results from PLC hydrolysis. More-
over, our experiments reveal a key additional element not refl  ected 
in the Fievet model of sequential activation: even when ERM pro-
teins are phosphorylated, their function largely depends on mem-
brane PIP2. 
  Results 
  Activation of PLC is essential for 
SDF-1  –  induced ERM protein release from 
cortical membrane and dephosphorylation 
  We hypothesized that ERM protein inactivation might be one 
of the components of the migratory response that is dependent 
on PLC activation. The affect of PLC inhibitors on ERM 
for a fl  exible migration-capable cell (  Brown et al., 2001  ). Be-
cause ERMs provide a conformationally regulated connection 
from the cortical actin cytoskeleton to the plasma membrane 
(  Bretscher et al., 2002  ;   Fievet et al., 2007  ;   Hughes and Fehon, 
2007  ;   Niggli and Rossy, 2008  ), rapid conversion of ERMs from 
their active to inactive conformations plays a key role in this 
process (  Brown et al., 2003  ;   Ivetic and Ridley, 2004  ). 
  Proteins of the PLC family are critical mediators of signal 
transduction, especially for GPCRs such as chemokine receptors 
(  Rhee, 2001  ). Proteins of this family are most widely known for 
their generation of two key mediators: a membrane-bound medi-
ator, DAG, and a soluble mediator of Ca 
2+   release, IP3, which 
play multiple functions in diversifi  ed pathways. Less frequently 
discussed is the functional impact of local reduction of PIP2 in 
the plasma membrane that results from PLC-mediated hydrolysis 
of PIP2. Such changes in PIP2 have the potential to infl  uence 
many molecules/processes such as ion channels and cytoskeleton 
(  Janmey and Lindberg, 2004  ;   McLaughlin and Murray, 2005  ). 
  We investigated the potential involvement of PIP2 and PLC 
in chemokine-induced ERM protein inactivation in lymphocytes 
  Figure 1.       SDF-1  –  induced ERM protein dephosphorylation depends on PLC signaling.   (A) Detection of ERM protein phosphorylation by WB in SDF-1  –
    stimulated PBT. Freshly isolated PBTs from a healthy donor were preincubated with PLC inhibitor U73122, its nonfunctional analogue U73433, or PI3-K in-
hibitor Ly294002 for 10 min and stimulated with/without SDF-1 or PLC activator m-3M3FBS for 45 s. Note that phosphorylated moesin and ezrin are both 
present in PBT but run as a single band under these conditions. (B) Detection of both moesin and ezrin protein dephosphorylation by WB in SDF-1  –  stimu-
lated PBT. The samples were prepared as in A but were resolved by running on SDS 4  –  20% Tris-glycine gels to separate moesin from ezrin. The top panel 
shows a blot for pERM; the top band is ezrin, and the bottom band is moesin. The middle and bottom panels show WB with antiezrin rabbit polyclonal 
antibody and antiezrin mouse mAb. (C) Quantitative analysis of data from B using Odyssey software (version 3.0; LI-COR Biosciences). CT, control.     453 PLC HYDROLYSIS OF PIP2 RELEASES ERM FROM MEMBRANE   • Hao et al. 
PI3-K inhibitor do not block these processes. In addition, the PLC 
activator m-3M3FBS was tested to determine whether activation 
of PLC by itself will lead to ERM protein dephosphorylation and 
disassociation from the membrane. Indeed, treatment of PBTs 
with m-3M3FBS induced ERM protein dephosphorylation and 
disassociation from CD44 (  Fig. 2  ). Thus, PLC mediates SDF-1 
stimulation-induced ERM protein dephosphorylation and dis-
association from cortical membrane. 
  A complementary biochemical approach was used to con-
fi  rm SDF-1  –  triggered release of ERM proteins from membrane: 
sonication and ultracentrifugation to separate a membrane-enriched 
pellet P100 and a soluble (cytosolic) fraction S100 (e.g.,   Frantz 
et al., 2007  ). The results (  Fig. 3  ) show that (a) SDF-1 treatment in-
duces substantial release of moesin and ezrin from the P100 mem-
brane-associated pellet, and (b) the active PLC inhibitor U73122 
abrogates that release. 
  Active PLC induces ERM protein 
dephosphorylation, release from the 
membrane, and reduction of 
membrane PIP2 
  To verify genetically that the activation of PLC induces ERM 
protein dephosphorylation, dominant active or inactive PLC 
constructs were transfected into Jurkat T cells. Transient over-
expression of the constitutively active PLC-    1 NN (having two 
instances of the N-terminal SH2 domain) construct in Jurkat 
cells induces ERM protein dephosphorylation (assessed by 
Western blot [WB]), but the inactive Y783F mutant (  Serrano 
et al., 2005  ) does not (  Fig. 4 A  ). Immunofl  uorescent analysis of 
cells transfected with constitutively active PLC confi  rms a re-
duction in pERM and redistribution of the remaining pERM 
away from the plasma membrane (  Fig. 4 B  ). A complementary 
approach by which to assess membrane localization of moesin 
is by cotransfection of the PLC constructs with moesin-GFP 
(  Fig. 4, C   [C1/C2] and   D  ). Moesin-GFP is enriched almost two-
fold at the plasma membrane in the presence of the inactive 
protein inactivation was therefore assessed using two readouts: 
dephosphorylation of ERM proteins and their dissociation from 
the membrane. SDF-1  –  induced ERM protein dephosphory-
lation is effi  ciently blocked in peripheral blood T cells (PBTs) 
pretreated with U73122 but not with U73433, the inactive ana-
logue (  Fig. 1 A  ). Conversely, the PLC activator m-3M3FBS in-
duces ERM protein dephosphorylation. In contrast, the PI3-K 
inhibitor Ly294002 does not inhibit ERM protein dephosphory-
lation (  Fig. 1 A  ). Similar results were obtained with the Jurkat 
T cell line (unpublished data). Thus, PLC activation is neces-
sary for SDF-1  –  induced rapid ERM protein dephosphorylation 
and is suffi  cient to initiate ERM protein dephosphorylation. 
  Lymphocytes express both moesin and ezrin, which are 
functionally similar in many respects. However, moesin and 
ezrin have also been reported to have some functional differ-
ences; e.g., in regulation of their localization in T cells (  Ilani 
et al., 2007  ). Using PAGE conditions optimized for resolving 
ezrin and moesin, we fi  nd that both undergo SDF-1  –  induced 
dephosphorylation and that dephosphorylation of both is sensi-
tive to the PLC inhibitor U73122 (  Fig. 1, B and C  ). 
 Immunofl  uorescence microscopy of lymphocytes under 
these stimulation conditions indicated that ERM protein dissocia-
tion from membrane accompanies the dephosphorylation ( Fig. 2 ). 
In untreated primary T lymphocytes, pERM proteins (  Fig. 2  , 
green) almost completely colocalize with the transmembrane 
molecule CD44 (  Fig. 2  , red) at the cell periphery. The staining of 
pERM is punctate (consistent with enrichment in microvilli) and 
strong. After the cells are stimulated with SDF-1, the CD44 re-
mains in the membrane but is often polarized toward the uropod, 
as previously described (  del Pozo et al., 1995  ). pERM staining is 
weak (refl  ecting partial dephosphorylation), diffuse, and not well 
localized with CD44 (  Fig. 2  , magnifi   cation), indicating that 
pERM was released from its membrane association. The PLC in-
hibitor U73122 blocks the SDF-1  –  induced cell polarization, the 
decrease in pERM staining, and the delocalization of pERM from 
the membrane (  Fig. 2  ). The inactive analogue U73433 and the 
  Figure 2.       SDF-1  –  induced delocalization of 
ERM proteins from plasma membrane depends 
on PLC signaling.   Immunoﬂ  uorescence analysis 
of PBT treated as in   Fig. 1  . After treatments, the 
cells were subjected to ﬁ  xation and immuno-
ﬂ  uorescence staining. The third row shows an 
overlay of CD44 and pERM, and the fourth 
row shows a higher magniﬁ   cation of boxed 
regions in the third row, which highlight either 
colocalization of pERM with CD44 or lack 
thereof. The ﬁ  fth row shows differential inter-
ference contrast (DIC) images displaying cell 
polarization. CT, control.     JCB • VOLUME 184 • NUMBER 3 • 2009  454
  Reduction of PIP2 concentration induces 
moesin and ezrin release from cortical 
membrane in Jurkat cells 
  To directly test whether the depletion of PIP2 suffi  ces to induce 
ERM protein dissociation from membrane in cells, we experi-
mentally decreased the levels of PIP2 using a recently described 
approach involving drug-inducible recruitment of type IV phos-
phoinositide 5-phosphatase (5-ptase) to the plasma membrane 
to acutely reduce PIP2 (  Heo et al., 2006  ;   Suh et al., 2006  ;   Varnai 
et al., 2006  ;   van Zeijl et al., 2007  ). This approach exploits 
rapamycin-induced heterodimerization of the CFP-tagged plasma 
membrane – targeted  FRB  (FK-506 – binding  protein  [FKBP] –
  rapamycin binding) fragment of mTOR with the monomeric 
RFP (mRFP)  –  tagged 5-ptase fused to FKBP12. Upon the addi-
tion of rapamycin, the 5-ptase enzyme is recruited to the plasma 
membrane and causes rapid hydrolysis of PIP2 at the 5 position 
to generate PI4P. Functionality of this strategy was confi  rmed 
by the fi  nding that addition of rapamycin induces the mem-
brane recruitment of 5-ptase and the loss of GFP-PH membrane 
localization (  Fig. 5     A  , bottom left; and Fig. S1, available at 
PLC construct but loses its membrane enrichment in the pres-
ence of the constitutively active PLC construct. 
  The foregoing analyses demonstrate that PLC is necessary 
and suffi  cient for ERM protein inactivation but do not address 
which aspect of PLC signaling is involved. The most investigated 
aspects of PLC signaling are the second messengers DAG and 
IP3 (with its attendant Ca 
2+   fl ux). However, PLC activation also 
reduces the PIP2 level that, we hypothesized, could mediate 
ERM protein inactivation. The GFP-tagged pleckstrin homology 
(PH) domain of PLC-   (GFP-PH) was used as a reporter for PIP2 
levels. In untransfected Jurkat cells, pERM is highly colocalized 
with the GFP-PH domain, indicating high PIP2 levels in the vi-
cinity of pERM (  Fig. 4 B  ). Transfection of the constitutively ac-
tive PLC construct abolishes the plasma membrane enrichment 
of the GFP-PH domain, documenting that it causes reduction in 
PIP2 (concurrent with inducing dephosphorylation of ERM pro-
teins and delocalization of ERM proteins from the membrane). 
Moreover, exposure of the cells to either SDF-1 or PLC activator 
induces redistribution of GFP-PH into the cytoplasm (  Fig. 4 E  ). 
Thus, these stimulations indeed induce hydrolysis of PIP2. 
  Figure 3.       SDF-1  –  induced ERM protein release from the membrane-enriched fraction depends on PLC signaling.   (A) Freshly isolated PBTs were pretreated 
with the indicated inhibitors at 37  °  C for 15 min, and cells were stimulated with SDF-1 at 37  °  C for 45 s. Subcellular fractionation by sonication and 
centrifugation was performed as described in Materials and methods. Total indicates postnuclear supernatant, S100 indicates soluble cytosolic fraction 
(S100) thereof obtained by centrifugation of postnuclear supernatant at 100,000   g  , and P100 indicates pellet (P100) whose enrichment in membrane 
is documented by WB for MHC-I. White line indicates that intervening lanes have been spliced out. (B) Quantitative analysis of data from A by Odyssey 
software (version 3.0). SDF-1 stimulation induces release of both moesin and ezrin from membrane. This release can only be prevented by PLC inhibitor 
U73122 but not by PI3-K inhibitor. CT, control.     455 PLC HYDROLYSIS OF PIP2 RELEASES ERM FROM MEMBRANE   • Hao et al. 
neither the PH domain reporter nor moesin-GFP loses their mem-
brane enrichment after rapamycin treatment ( Fig.  5  A ).  Thus, 
PIP2 hydrolysis alone induces release of moesin and ezrin from 
the plasma membrane. 
  Moesin and ezrin membrane association is 
substantially PIP2 dependent even with 
C-terminal phosphorylation (with or without 
multilysine mutation) 
 The relationships between PIP2 binding, C-terminal phosphory-
lation, membrane association, and conformational activation 
are central issues in understanding ERM proteins. Therefore, 
we fi  rst assessed whether C-terminal phosphorylation controls 
http://www.jcb.org/cgi/content/full/jcb.200807047/DC1). To test 
whether this inducible reduction of PIP2 can induce dissociation 
of ERM proteins from the membrane, Jurkat cells were trans-
fected with GFP-tagged moesin and ezrin constructs along with 
the membrane-targeted FRB-CFP and the mRFP-FKBP  –  5-ptase 
domain constructs. Rapamycin-induced recruitment of the 5-ptase 
to the membrane causes translocation of moesin-GFP and ezrin-
GFP into the cytosol (  Fig. 5 A   and Fig. S1). Quantitative analy-
sis (  Fig. 5 B  ) demonstrates a 1.7-fold enrichment of moesin 
and a more modest 1.2-fold enrichment of ezrin at the mem-
brane before rapamycin but abolition of that enrichment after 
rapamycin. Control transfections (in which the 5-ptase con-
struct is replaced by one lacking the ptase domain) show that 
  Figure 4.       Transfection with constitutively active PLC induces ERM protein dephosphorylation and release from the plasma membrane.   (A) Jurkat cells 
were transfected with the indicated PLC-    1 constructs (NN, constitutively active; or Y783F, inactive) or construct-encoding GFP-PH and analyzed by 
WB. Expression of PLC-    1 in Jurkat does not inﬂ  uence the expression of moesin constructs (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200807047/DC1). (B) Imaging of control cells (top) compared with cells transfected with constitutively active NN PLC-    1 construct (middle) or with 
inactive PLC-    1 Y783F (bottom). Markers examined are the transfected PLC (anti-HA antibody, purple), pERM level (red), and transfected GFP-PH localiza-
tion. (C) Fluorescent analysis of Jurkat cells cotransfected with GFP-moesin (wt or T558D) and PLC-    1 constructs (detected with anti-HA antibody [red]). 
(D) Quantitative analysis of data from C (  n   = 10 for each condition). Quantitative analysis was performed as described in Materials and methods. (E) SDF-1 
stimulation induces hydrolysis of PIP2. Jurkat cells were transfected with GFP-tagged PH domain construct and analyzed by immunoﬂ  uorescence microscopy 
after SDF-1 or PLC activator treatment. Note that unlike PBTs, Jurkat cells do not undergo striking shape change (polarization) in response to SDF-1. Error 
bars indicate SEM. DIC, differential interference contrast.     JCB • VOLUME 184 • NUMBER 3 • 2009  456
threonine 558 side chain participates in stabilizing the closure 
of moesin FERM to C terminus and that mutation of threonine 
to alanine therefore causes limited relaxation of autoinhibi-
tion. Investigation of ezrin confi  rmed that it resembled moesin 
in three key respects (  Fig. 5, A and B  ): membrane localization 
of the wt protein depended on PIP2, the phosphomimetic mu-
tant protein had augmented membrane localization, and the 
phosphomimetic mutant protein continued to depend on PIP2 
for most of its membrane localization. 
  Exploration of issues related to PIP2-mediated activation 
of ERMs has been facilitated by the description of an ezrin con-
struct that is defective in PIP2 binding as a result of four K to N 
mutations (K4N) in the FERM domain (  Barret et al., 2000  ; 
  Fievet et al., 2004  ). Previous fi  ndings that the full-length ezrin 
K4N mutant fails to associate with the membrane (  Barret et al., 
2000  ;   Fievet et al., 2004  ) are confi  rmed by our investigations of 
both moesin and ezrin (  Fig. 5, A and B  ). Moreover, our fi  ndings 
confi  rm those of   Fievet et al. (2004)   that the mutations mimick-
ing phosphorylation (moesin T558D and ezrin T567D) partially 
restore membrane association (  Fig. 5, A and B  ).   Fievet et al. 
(2004)   interpreted their results to indicate that this association 
membrane association by monitoring GFP-tagged phospho-
mimetic moesin (T558D) in Jurkat cells. The phosphomimetic 
moesin (T558D) construct was more highly enriched at the 
plasma membrane than wild type (wt;   Fig. 4 D  , 3.4 vs. 1.8; and 
  Fig. 5 B  , 3.3 vs. 1.7). Surprisingly, the membrane association of 
the T558D construct was completely disrupted in cells express-
ing the constitutively active PLC-    1 NN construct (  Fig. 4, 
C and D  ). Thus, although ERM protein phosphorylation augments 
membrane association, action of PLC can abolish membrane 
association even of the phosphorylated form. 
  We tested the ability of PIP2 hydrolysis by itself (by 5-
ptase recruitment) to trigger disassociation of phosphomimetic 
moesin (  Fig. 5, A and B  ). After rapamycin treatment, there is 
marked redistribution of T558D to the cytosol. But even after 
treatment, the T558D protein has limited residual enrichment 
at the membrane (unlike wt after rapamycin). The residual 
enrichment suggests that phosphorylation cooperates (or 
synergizes) with PIP2 in activating ERM proteins rather than 
substituting for it (see Discussion). It is interesting that the 
T558A mutation has a behavior intermediate between wt and 
T558D (  Fig. 5, A and B  ). We interpret this to indicate that the 
  Figure 5.       Membrane translocation of type 
IV 5-ptase reduces plasma membrane PIP2 
and releases moesin and ezrin from the mem-
brane.   (A) Jurkat cells were transfected with 
GFP-tagged PH domain or the indicated GFP-
moesin or GFP-ezrin constructs, along with the 
membrane-targeted FRB-CFP and the mRFP-
FKBP domain constructs (with or without type 
IV 5-ptase domain as indicated), and were 
analyzed by ﬂ   uorescence microscopy before 
and after rapamycin (Rapa) treatment. GFP 
ﬂ  uorescence is shown. mRFP-FKBP, mRFP-FKBP  –
  5-ptase, and FRB-CFP ﬂ  uorescence images are 
shown in Fig. S1 (available at http://www.jcb
.org/cgi/content/full/jcb.200807047/DC1). 
(B) Quantitative analysis of the membrane 
enrichment of moesin, ezrin, or PH domain 
constructs (  n   = 10 for each condition) was per-
formed as described in Materials and meth-
ods. Error bars indicate SEM.     457 PLC HYDROLYSIS OF PIP2 RELEASES ERM FROM MEMBRANE   • Hao et al. 
cytoplasmic tails should depend on PIP2 in a manner similar to 
that observed with moesin mutant constructs in intact cells. We 
restricted our analysis of that question to one tail, CD44, be-
cause the lipid dependence of the four tails tested is similar. 
Results of such testing (  Fig. 6 B  ) demonstrate a virtually perfect 
concordance. The T558D mutant displays enhanced binding in 
the presence of PIP2 (relative to wt) and a small amount of PIP2-
independent binding (not observed in wt) exactly as shown in 
  Fig. 5 A  . The K4N shows minimal binding even in the presence 
of PIP2, but superimposition of the T558D mutation enables 
PIP2-dependent binding ( Fig. 6 B ). These fi  ndings are the fi  rst to 
demonstrate in vitro that PIP2 binding is required even with a 
phosphomimetic moesin protein. 
  Decrease in PIP2 induces 
dephosphorylation of ERM proteins 
  The foregoing analyses demonstrate the dominant role of PIP2 
rather than phosphorylation in controlling both localization at 
the cell membrane in cells and binding to cytoplasmic tails 
in vitro. Therefore, ERM protein dephosphorylation observed 
during chemokine activation cannot be the prime mediator of 
ERM protein delocalization from the membrane. Instead, we pre-
dicted ERM protein dephosphorylation would result from PIP2 
hydrolysis. The model system of rapamycin-induced 5-ptase 
recruitment allows testing whether PIP2 hydrolysis by itself is 
suffi  cient. The results demonstrate that rapamycin treatment in-
duces ERM protein dephosphorylation (  Fig. 7, A and B  ). Thus, 
hydrolysis of PIP2 triggers ERM protein release from mem-
brane and dephosphorylation. 
was PIP2 independent. In contrast, our analysis with rapamycin-
induced PIP2 hydrolysis indicates that the membrane associa-
tion of this K4N mutant is still entirely PIP2 dependent (see 
Discussion). Thus, additional elements of moesin beyond these 
four K residues can mediate PIP2 binding in intact cells. 
  PIP2 contributes to opening autoinhibited 
ERM proteins for binding to CD44, CD43, 
and ICAMs even with phosphomimetic 
ERM proteins 
  ERM proteins have been shown to bind in vitro to cytoplasmic 
tails of various transmembrane proteins (including CD43, CD44, 
and ICAMs). Although many of the studies have demonstrated 
PIP2 dependence of those interactions (  Hirao et al., 1996  ;   Heiska 
et al., 1998  ;   Serrador et al., 2002  ), some have not demonstrated 
PIP2 dependence (  Yonemura et al., 1998  ), and often other phos-
pholipids have not been assessed for their ability to replace that 
requirement. Therefore, we reassessed under standardized condi-
tions whether interaction of the cytoplasmic tails of four trans-
membrane proteins with moesin depended on phospholipid. The 
results demonstrate that the binding of all of four GST-tagged 
tails to moesin is dependent on the presence of PIP2 and is not re-
placed by phosphatidylserine (  Fig. 6 A  ). It is notable that for each 
of the four tails, the only other phosphoinositide of reasonable 
abundance in cellular membrane, PI4P (  Stephens et al., 1993  ; 
  Balla, 2005  ), is much less effi  cient in stabilizing the interaction. 
  Localization of ERM proteins at the cell membrane may 
be substantially mediated by binding of ERM protein to cyto-
plasmic tails. If so, in vitro binding of mutant ERM proteins to 
  Figure 6.       PIP2 binding is required for the association of moesin with the cytoplasmic tails of CD44, CD43, ICAM2, and ICAM3.   (A) Effects of phospholip-
ids or IP3 on the interaction between moesin and cytoplasmic tails of CD44, CD43, ICAM2, and ICAM3. The bound proteins by GST-tagged tails in the 
pellet were detected with antimoesin antibody and are shown in the top panel. Arrowheads indicate the intact protein in the lanes where degredation 
products also exist. (B) The effects of T558D mutation mimicking phosphorylation, K4N mutations, or their combination on the activation of moesin for 
CD44 tail binding. The bound proteins shown in the top panel were detected by WB. Further characterization of the recombinant protein is shown in 
Fig. S2 (available at http://www.jcb.org/cgi/content/full/jcb.200807047/DC1). GST (as control) or GST fusion proteins in the pellet were detected with 
Coomassie blue staining and are shown in the bottom panels. Each lane represents 40% of the amount of protein in the pellet. PI, phosphatidylinositol; 
PS, phosphatidylserine.     JCB • VOLUME 184 • NUMBER 3 • 2009  458
(  Heo et al., 2006  ). Finally, and most relevant to this study, 
EGF-mediated activation of PLC reduces membrane PIP2 and 
releases cofi  lin from the plasma membrane (  van Rheenen et al., 
2007  ). Both this study and the aforementioned cofi  lin study cor-
roborate the view that membrane PIP2 is a key regulator of mol-
ecules (such as cofi  lin and ERM proteins) that bind and infl  uence 
the cortical cytoskeleton. 
  Although extensive work has been done on ERM protein 
interaction with phospholipid in vitro, in vivo studies have been 
limited (  Barret et al., 2000  ;   Yonemura et al., 2002  ;   Fievet et al., 
2004  ;   Rasmussen et al., 2008  ). The fi  rst in vivo evidence for the 
hypothesis that PIP2 plays a role in membrane localization of 
ERM proteins was based on mutational analysis (  Barret et al., 
2000  ); the authors mutated pairs of positively charged lysine res-
idues in the FERM domain that they predicted would mediate 
PIP2 binding and demonstrated that the mutation of two such 
pairs (a construct we refer to as K4N-moesin) impaired PIP2 
binding in vitro and membrane localization in vivo of ERM pro-
tein.   Yonemura et al. (2002)   extended the in vivo understanding 
greatly by three key fi  ndings: ERM protein phosphorylation was 
not always required for membrane association, enhancing PIP2 
by overexpression of PI4P5K-augmented ERM protein mem-
brane association, and microinjection of neomycin reduced ERM 
membrane association apparently by reduction of available PIP2. 
The third study implicating PIP2 in ERM protein activation in 
cells described the use of a membrane-localized lipid phospha-
tase domain to blunt osmotic stress-induced ERM protein activa-
tion (  Rasmussen et al., 2008  ). The fourth key study used the 
K4N-moesin to explore the relationship between PIP2 binding 
and phosphorylation and generated results supporting a model 
that PIP2 binding occurs fi  rst, causing release of autoinhibition 
and consequently enabling phosphorylation (  Fievet et al., 2004  ). 
  In contrast to the   Fievet et al. (2004)   study, we show that 
ERM proteins depend on PIP2 for membrane association even 
after phosphorylation (  Fig. 4  , C4; and   Fig. 5  ).   Fievet et al. (2004)   
concluded that PIP2 binding was a mechanism to activate ERM 
proteins, which after subsequent ERM phosphorylation became 
unnecessary for membrane binding. Two key elements of our 
study are critical to the altered interpretation. The fi  rst element is 
the use of drug-induced 5-ptase membrane localization to acutely 
alter PIP2 levels. This approach allows a clear demonstration that 
the localization of phosphomimetic moesin protein at the mem-
brane is still dependent on PIP2. The second element is quantita-
tion of the extent of enrichment of wt and mutant moesin constructs 
at the membrane. Although the phosphomimetic K4N protein is 
somewhat enriched at the membrane, its degree of enrichment is 
much less than the corresponding construct without the K4N mu-
tation. Thus, even in the presence of pseudophosphorylation, PIP2 
binding by those four K residues is still of major importance. 
  The foregoing fi  nding, i.e., continued dependence of pERM 
on PIP2 for membrane association, has critical implications for 
the process that we set out to study, namely acute inactivation 
of lymphocyte ERM proteins by chemokine stimulation. If 
the Fievet model were correct, ERM inactivation should not 
be inducible by reduction of PIP2 because lymphocyte ERM 
proteins are substantially phosphorylated in the cortex (  Brown 
et al., 2003  ), and phosphorylation was interpreted to make ERM 
  Discussion 
  Rapid inactivation of ERM proteins is especially relevant to 
hematopoietic cells because of the involvement of ERM proteins 
in the rapid transition from quiescent spherical cells to polarized 
migratory cells (  Brown et al., 2001  ). This study addresses three 
aspects of ERM protein inactivation. First, PLC activity is required 
for chemokine-mediated dissociation of ERM proteins from the 
membrane. Second, in contrast to the typical emphasis on DAG 
and IP3 signaling in hematopoietic cells, our results demonstrate 
the importance of PIP2 hydrolysis because reduction in PIP2 lev-
els is suffi  cient to induce ERM protein dissociation from the 
membrane. Third, our results indicate that ERM phosphorylation 
is not suffi  cient to maintain ERM proteins at the membrane. Phos-
phorylation of ERM proteins also fails to eliminate their depen-
dence on PIP2 for in vitro binding to cytoplasmic tails. Furthermore, 
reduction in PIP2 in vivo is suffi  cient to induce ERM protein de-
phosphorylation. The discussion focuses on integrating these fi  nd-
ings into a broader understanding of ERM proteins. 
  Our study demonstrates that PLC mediates chemokine-
  induced inactivation of ERM proteins in lymphocytes, which is 
the fi  rst implication of PLC in ERM protein inactivation in any 
cell type. This inactivation is initiated by chemokine binding to a 
GPCR, CXCR4, and thus fi  ts the paradigm that PLC activation 
commonly results from GPCR signaling (  Rhee, 2001  ). Identifi  -
cation of the relevant PLC genes has been impeded by the exis-
tence of more than a dozen PLC isoforms. Previous studies 
implicate PLC    2/   3 as limited contributors to T lymphocyte 
migration in double knockout mice (  Bach et al., 2007  ), but our 
experiments do not show a major decrease in chemokine-induced 
ERM protein dephosphorylation in such mice (unpublished 
data). We chose PLC-    1 for our genetic confi  rmation of PLC  ’  s 
capacity to mediate ERM protein inactivation (  Fig. 4  ) because 
that isoform is strongly expressed in T cells, and recent evidence 
indicates that isoform (  Dar and Knechtle, 2007  ) or a closely re-
lated isoform (  de Gorter et al., 2007  ) is involved in chemokine-
induced migration. Moreover, the T cell receptor also mediates 
ERM protein dephosphorylation and membrane relaxation 
(  Faure et al., 2004  ) via a signaling pathway that depends on the 
same two molecules that mediate PLC-    1 activation, Vav-1 and 
Rac1 (  Zugaza et al., 2004  ). Identifi  cation of the PLC isoforms 
that mediate chemokine-induced ERM inactivation in primary 
T cells is an important question for future research. 
  This study shows that inactivation of ERMs in lympho-
cytes by PLC can be explained by PLC-mediated reduction of 
plasma membrane PIP2. The effi  cacy of these molecular mech-
anisms is established using the recently devised strategy for in-
ducing rapid hydrolysis of PIP2 by drug-induced translocation 
of 5-ptase (  Heo et al., 2006  ;   Varnai et al., 2006  ). This approach 
provides confi  rmation of the view that plasma membrane PIP2 
is a regulator of processes/assemblies at the plasma membrane, 
especially cytoskeleton (  Janmey and Lindberg, 2004  ;   McLaughlin 
and Murray, 2005  ). For example, this approach has been used 
(a) to characterize regulatory effects of PIP2 on ion channels 
and gap junctions (  Varnai et al., 2006  ;   van Zeijl et al., 2007  ) and 
(b) to analyze the role of positively charged clusters of amino 
acids in recruiting proteins to the plasma membrane via PIP2 459 PLC HYDROLYSIS OF PIP2 RELEASES ERM FROM MEMBRANE   • Hao et al. 
for PIP2 for enrichment at the membrane in vivo. Therefore, our 
fi  ndings suggest that PLC-mediated inactivation of ERM proteins 
is dependent in part on reducing the PIP2-dependent binding of 
ERM to cytoplasmic tails. The mechanism for this PIP2 depen-
dence seems to relate primarily to PIP2-mediated conformation 
activation of intact ERM proteins rather than to a direct affect on 
the cytoplasmic tails because binding of cytoplasmic tails to 
FERM domain (as opposed to intact ERM protein) is not depen-
dent on PIP2 (  Hirao et al., 1996  ; and unpublished data). 
  It is worth emphasizing that our fi  ndings are consistent with 
preexisting views that (a) PIP2 induces conformational activation 
that allows C-terminal phosphorylation and that (b) C-terminal 
phosphorylation also promotes activation (e.g., the fi  nding that 
moesin T558D shows greater membrane enrichment than wt; 
  Fig. 4 C  , C3 vs. C1; and   Fig. 5 A  , wt vs. T558D). However, our 
fi  ndings contradict the view that C-terminal phosphorylation fully 
replaces the PIP2 requirement, as seemed to be the conclusions of 
  Fievet et al. (2004)  . Rather, our evidence supports a more com-
plex view of cooperativity, either for in vivo membrane localiza-
tion or in vitro association with cytoplasmic tails. Two fi  ndings 
are worth emphasizing in this context. First, in cells, the phospho-
mimetic moesin construct resembles the wt in depending on PIP2 
but unlike the wt cannot be fully dissociated by 5-ptase (  Fig. 5 A  ). 
proteins independent of PIP2 (  Fievet et al., 2004  ). In contrast, 
because our study shows that pERM continues to depend on 
PIP2 for membrane association, reduction of PIP2 by PLC is an 
appealing mechanism for initiating ERM protein inactivation. 
Indeed, our study demonstrates that PLC activation is necessary 
for chemokine-induced ERM protein release from the cortex. 
  Results of in vitro experiments of moesin binding to cyto-
plasmic tails (  Fig. 6  ) provide a candidate mechanism for the 
in vivo behavior. They suggest that binding of ERM proteins to cyto-
plasmic tails directly contributes to the in vivo requirement for 
PIP2 in ERM protein association with membrane. We extend 
what was previously known (  Fig. 6  ;   Hirao et al., 1996  ;   Heiska 
et al., 1998  ;   Yonemura et al., 1998  ;   Serrador et al., 2002  ). First, to 
address confl  icting data in the literature, we directly compared 
the tails of four relevant cytoplasmic proteins and examined the 
ability of other phospholipids to replace PIP2 requirement. The 
results demonstrate that all of the tails are dependent on PIP2 (un-
like a previous study [  Yonemura et al., 1998  ]) and that PIP2 can-
not be replaced by phosphatidylserine. Second, they demonstrate 
that phosphorylation cannot replace PIP2 in promoting ERM 
protein binding to cytoplasmic tails in vitro. Thus, there is a paral-
lel between the failure of phosphorylation to substitute for PIP2 
in vitro for binding to cytoplasmic tails and its failure to substitute 
  Figure 7.       Type IV 5-ptase mediates decrease 
of PIP2 and induces endogenous ERM protein 
dephosphorylation in Jurkat cells.   (A) Immuno-
ﬂ   uorescence analysis of ERM protein phos-
phorylation in cells transfected with PH-GFP 
construct, the membrane-targeted FRB-CFP, 
and the mRFP-FKBP domain construct (with or 
without type IV 5-ptase domain as indicated). 
(B) Quantitative analysis of pERM (  n   = 10 for 
each condition). Error bars indicate SEM. Rapa, 
rapamycin; CT, control.     JCB • VOLUME 184 • NUMBER 3 • 2009  460
  SDF-1 treatment, subcellular fractionation, and WB analysis 
  Freshly isolated PBTs were cultured in medium A (HBSS containing 0.3% 
BSA) for 2 h at 37  °  C for recovery (we found this recovery process is impor-
tant for getting a better response to SDF-1 stimulation). Such PBTs or Jurkat 
cells were treated with or without SDF-1 at a ﬁ  nal concentration of 200 ng/ml 
at 37  °  C for 45 s (or an indicated time). For routine WB analysis, samples 
were immediately lysed with sample buffer containing 0.2% SDS. Samples 
were homogenized by sonication and boiled for 3 min. For subcellular frac-
tionation, the samples were mixed with an equal volume of 2  ×   sonication 
buffer (20 mM Hepes, 300 mm NaCl, 2 mM EDTA, protein inhibitor, and 
50 nM calyculin A) and immediately sonicated for 3 min at 4  °  C. Nuclei and 
cellular debris were pelleted by centrifugation at 2,000   g   for 5 min at 4  °  C, 
and the resulting postnuclear supernatant was fractionated by centrifugation 
at 100,000   g   for 1 h at 4  °  C to obtain the cytosolic fraction (S100) and the 
membrane-containing pellet (P100). The P100 pellets were washed once 
with 1  ×   sonication buffer. The S100 and P100 fractions were denatured by 
boiling in Laemmli sample buffer. For WB analysis, equal volumes of sam-
ples from each treatment were resolved by 4  –  12% SDS-NuPAGE gels (Invit-
rogen) or 4  –  20% Tris-glycine gel, transferred to nitrocellulose membranes, 
and analyzed by WB with the aforementioned antibodies using an infrared 
imaging system (Odyssey; LI-COR Biosciences) or ECL (GE Healthcare). In 
the experiments with inhibitors, the cells were pretreated with the indicated 
inhibitors (2.5   μ  M U73122 for PLC or analogue U73433; or 10   μ  M 
Ly294002 for PI3-K) at 37  °  C for 10 min and stimulation with 200 ng/ml 
SDF-1 for 45 s (or an indicated time). PLC activator m-3M3FBS treatment 
was done as with SDF-1 stimulation except using 200   μ  M m-3M3FBS. 
  Immunoﬂ  uorescence microscopy 
  For immunoﬂ  uorescence analysis of cells with SDF-1 stimulation, PBTs at 10 
6   
cells in 300   μ  l of medium A with/without inhibitors, as indicated in   Fig. 1  , 
were incubated for 10 min at 37  °  C and dropped onto the glass bottom of 
35-mm cultureware dishes (MatTek) precoated with poly-  L  -lysine (Sigma-
  Aldrich). Cells were allowed to settle for 10 min at 37  °  C, and 1.0 ml of me-
dium A with/without SDF-1 (200 ng/ml ﬁ  nal) was added into each dish to 
stimulate cells for 45 s at 37  °  C. Cells were ﬁ  xed by the addition of ice-cold 
4% paraformaldehyde solution (Sigma-Aldrich). After 10 min at RT, sam-
ples were washed with PBS, permeabilized with 0.2% Triton X-100, and 
blocked for 1 h at RT in PBS with 3% BSA. Primary antibodies were added 
for 1 h at RT in PBS with 3% BSA. After washing, Alexa Fluor 546  –   and/or 
488  –  conjugated secondary antibodies (Invitrogen) in PBS with 3% BSA 
were added for 1 h at RT. Samples were examined, and images were col-
lected using a confocal microscope (LSM510 META; Carl Zeiss, Inc.) 
equipped with a Plan Apochromat 63  ×   NA 1.4 oil immersion objective 
lens (Carl Zeiss, Inc.). The images were organized into ﬁ  gures using Photo-
shop (version 8.0; Adobe). 
  For translocation analysis of GFP-tagged constructs in individual 
cells, Jurkat cells were transfected with the various constructs (5   μ  g DNA/
plasmid) using an electroporator (300 V for 10 ms; BTX ECM 830; Har-
vard Apparatus). After electroporation, the cells were cultured for 48 h and 
used for analysis. For analysis of translocation of ERM protein, the cells 
were collected, washed once with PBS, and resuspended in medium A 
(prewarmed at 37  °  C), and the cells at     10 
6   cells in 200   μ  l were dropped 
onto the glass bottom of 35-mm cultureware dishes (MatTek) precoated with 
poly-  L  -lysine and were allowed to settle for 10 min at 37  °  C. 1.0 ml of me-
dium containing 0.36   μ  M rapamycin was added into the dish. After 5 min 
of incubation at 37  °  C, the media was poured off, and the cells were ﬁ  xed 
by the addition of ice-cold 4% paraformaldehyde solution immediately. 
After 10 min at RT, the cells were washed four times with PBS and examined 
using the same confocal microscopy conﬁ  guration as for PBT. Quantitative 
analysis was performed using the Imaging Examiner software (LSM; Carl 
Zeiss, Inc.). Because ﬂ   uorescence intensity was not uniform along the 
plasma membrane, quantitation along a single line across the cell was not 
sufﬁ  ciently robust. Instead, for each cell analyzed, a circumferential line 
was drawn manually at the plasma membrane, and another line was 
drawn just inside the plasma membrane in the cytosol. Membrane enrich-
ment for that cell is calculated as the mean ﬂ  uorescence of all pixels on the 
plasma membrane line divided by the mean ﬂ  uorescence of all pixels on 
the cytosol line, and enrichment reported for a cell preparation is the mean 
for 10 randomly chosen transfected cells. 
  In vitro pull-down analysis of the interaction with GST-tagged cytoplasmic 
tails of transmembrane protein 
  In brief, 1.0   μ  M puriﬁ  ed moesin (wild type or mutants) was incubated with 
a ﬁ  ve times molar excess of glutathione  –  Sepharose 4B bead-immobilized 
GST-tagged tail proteins in the presence of the indicated phospholipids 
(sonicated as described previously [  Hirao et al., 1996  ]; Avanti Polar 
Second, the most dramatic illustration of this cooperativity is with 
moesin K4N binding to the CD44 tail. PIP2 alone or the T558D 
mutation alone has little effect, but the combination dramatically 
augments binding (  Fig. 6 B  ). It is worth noting that the PIP2 
affect in this context must be independent of the K253/254 and 
K262/263, which have been mutated. Thus, this must refl  ect an 
independent structural role of PIP2 in inducing conformational 
change. The simplest hypothesis is that it refl  ects the PIP2 bind-
ing identifi  ed by x-ray crystallography, which promotes confor-
mational change in the FERM domain (  Hamada et al., 2000  ). 
  Among the rich literature on ERM protein activation, 
there is considerable work on cellular and biochemical pro-
cesses that activate ERM. In contrast, this study focuses on the 
processes that regulate acute inactivation. The results demon-
strate for the fi  rst time that PLC reduction of membrane PIP2 
initiates that inactivation. PIP2 hydrolysis by itself is suffi  cient 
to induce ERM protein dephosphorylation, indicating that 
PIP2 regulation is the primary mediator of both activation 
and inactivation. 
  Materials and methods 
  Cell lines and reagents 
  Jurkat T cell lines (American Type Culture Collection) were maintained 
in RPMI 1640 supplemented with 10% fetal bovine serum, 50   μ  M 
2-  mercaptoethanol, and penicillin-streptomycin (Invitrogen). Fresh human 
PBTs were isolated from the blood of healthy human volunteers by leuka-
pheresis and immunomagnetic negative selection as previously described 
(  Brown et al., 2003  ). The following antibodies were used: pERM mAb 
pT567, whose reactivity includes moesin pT558, ezrin pT567, and ra-
dixin pT564 (BD), rabbit polyclonal antibodies raised against human 
moesin 473  –  486,     -actin mouse mAb (Sigma-Aldrich), moesin-speciﬁ  c 
mAb 38/87 (NeoMarkers), major histocompatibility complex I  –  speciﬁ  c 
rabbit mAb (Epitomics), Alexa Fluor 488  –  conjugated CD44 mAb (Bio-
Legend), and HRP-conjugated Penta-His antibody (QIAGEN). PLC inhibi-
tor U73122, analogue U73433, PI3-K inhibitor Ly294002, and PLC 
activator m-3M3FBS were purchased from EMD. 
  DNA constructs and preparation of puriﬁ  ed proteins 
  The PLC-    1  –  PH-GFP construct was provided by M. Lemmon (University of 
Pennsylvania, Philadelphia, PA). CFP-tagged membrane-targeting construct 
containing FRB domain of human mTOR1 and mRFP-tagged human type IV 
5-ptase enzyme construct containing FKBP12 or mRFP-FKBP12 control con-
struct without type IV 5-ptase were provided by T. Balla (National Institute 
of Child Health and Human Development, Bethesda, MD). The dominant-
negative PLC construct Y783F has been previously described (  Irvin et al., 
2000  ). The constitutively active PLC-    1 NN construct was made by replac-
ing the carboxy-terminal SH2 domain with a second copy of the amino-
  terminal SH2 domain. It was chosen for this study because it is constitutively 
active in a broader range of cell types than others described previously 
(  DeBell et al., 2007  ). GFP-tagged constructs of moesin, ezrin, or mutants 
thereof were prepared in the pEGFP-N1/C1 vector (Clontech Laboratories, 
Inc.). Full-length moesin, moesin T558D, moesin K4N, and moesin K4N-
T558D with His  6   tagged at their C termini were prepared from clones con-
taining their coding DNA in the expression vector pET-23a 
+   (EMD) or 
pBAD-Myc-His (Invitrogen). To prepare GST-tagged transmembrane protein 
cytoplasmic tail constructs, including GST-CD44 (residues 291  –  361), GST-
CD43 (residues 276  –  400), GST-ICAM2 (residues 247  –  275), and GST-
ICAM3 (residues 508  –  547), DNA fragments were produced by RT-PCR 
with primers encoding the corresponding region, using total mRNA iso-
lated from human PBTs and subcloned into BamHI and SalI sites of pGEX-
4T-2 (GE Healthcare). Constructs with mutations were generated using the 
QuikChange site-directed mutagenesis kit (Agilent Technologies). All con-
structs and mutations were veriﬁ  ed by DNA sequencing. Puriﬁ  cation of the 
His  6  -tagged proteins was performed with the His-Bind kit (EMD), and puriﬁ  -
cation of the GST fusion proteins was performed as described in the GST 
Gene Fusion System Handbook (GE Healthcare). Purity was   >  95% and 
conﬁ  rmed by Coomassie blue staining after SDS-PAGE. 461 PLC HYDROLYSIS OF PIP2 RELEASES ERM FROM MEMBRANE   • Hao et al. 
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Lipids, Inc.) or IP3 (dissolved in water; Avanti Polar Lipids, Inc.) in 150   μ  l 
of buffer A (20 mM Tris-HCl, pH 7.5, 1 mM EGTA, 150 mM NaCl, 1 mM 
DTT, and 0.05% Tween 20) and incubated at 4  °  C on a rotating wheel for 
90 min. After centrifugation (600   g   for 3 min), the beads were washed 
twice with buffer A and dissolved in 20   μ  l of 2  ×   SDS-loading buffer. Two 
identical sets of samples were run using Nu-PAGE Bis-Tris gels (Invitrogen). 
One set of samples is used for detecting the amount of moesin or mutants 
bound in the beads by immunoblotting using antimoesin antibody or Penta-
His antibody, and another one is used for visualizing GST-tagged proteins 
by Coomassie blue staining after separation by SDS-PAGE. 
  Online supplemental material 
  Fig. S1 shows that recruitment of type IV 5-ptase to plasma membrane trig-
gers the translocation of PIP2 marker, moesin, or moesin mutant constructs 
into cytosol. Fig. S2 shows characterization of puriﬁ  ed recombinant pro-
teins by Coomassie blue staining after SDS-PAGE. Fig. S3 shows that ex-
pression of PLC-    1 in Jurkat does not inﬂ  uence the expression of moesin 
constructs. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807047/DC1. 
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